Examination Regarding the Simple Suspension Method using Oral Anticancer Drugs
10.14925/jjsp.35.1_34
- VernacularTitle:経口抗がん薬における簡易懸濁法の適応可否に関する検討
- Author:
Masahiro Murakami
;
Yoshihiko Ikemoto
;
Narumi Toya
;
Mihi Paku
;
Miyuki Okuyama
;
Kazuko Hatakeyama
;
Satoko Katsuragi
;
Masako Ohno
;
Hiroyuki Hichiya
;
Yoshito Zamami
;
Chikaaki Muro
;
Takeshi Kimura
;
Naomi Kurata
;
Manabu Amano
- Publication Type:Journal Article
- Keywords:
simple suspension method;
oral anticancer drug;
tube administration;
generic drug
- From:Japanese Journal of Social Pharmacy
2016;35(1):34-37
- CountryJapan
- Language:Japanese
-
Abstract:
To administer oral anticancer drugs safely, the simple suspension method has been introduced in many hospitals. Therefore, concerning drugs for which it is unclear whether or not this method is applicable, testing must be able to be conducted at any time. In this study, we investigated 20 oral anticancer drugs to expand information on the application of the simple suspension method. Disintegration/suspension and permeability tests were conducted, as described in the 3rd version of the Tube Administration Handbook for Oral Drugs. All products were disintegrated/suspended after 10 minutes. On permeability tests, there was no residue in any tube for tubal feeding. On the final evaluation, the products were regarded as suitable (grade 1). Bicalutamide tablets (80 mg, TCK and KN), which were analyzed in this study, were regarded as suitable (grade 1) on the final evaluation. On the other hand, the simple suspension method is not applicable for a brand-name drug, Casodex® tablets (80 mg). This may be related to the different additives. Furthermore, the results suggest that, even when the simple suspension method is not applicable for a brand-name drug, it may become applicable for generic drugs. This may provide a new merit for promoting the use of generic drugs.
